Skip to main content
logo
Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
4.350
-0.190 (-4.19%)
At close: Oct 30, 2025, 4:00 PM EDT
4.380
+0.030 (0.69%)
After-hours: Oct 30, 2025, 7:56 PM EDT

Prime Medicine Revenue

Prime Medicine had revenue of $1.12M in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to $4.96M, up 739.42% year-over-year. In the year 2024, Prime Medicine had annual revenue of $2.98M.

Revenue (ttm)
$4.96M
Revenue Growth
+739.42%
P/S Ratio
111.28
Revenue / Employee
$23,182
Employees
214
Market Cap
735.25M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20242.98M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 20205.21M--
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG56.37B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

PRME News

More News